Thierry D Flandre (Thierry G Flandre, Thierry Flandre)

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 7

Top Topics

Respiratory Tract

Recombinant Human

Top Venues

Toxicologic pathology

This page only lists publications with an associated author ORCID identifier.

Publications

Kyathanahalli S Janardhan, Radhakrishna Sura, Smita Salian-Mehta, Thierry D Flandre, Xavier Palazzi, Doris Zane, Bhanu Singh, Binod Jacob, Renee Rosemary Hukkanen, Muthafar Al-Haddawi, Bindu Bennet, Victoria Laast, Donna Lee, Richard Peterson, Annette Romeike, Frederic Schorsch, Magali Guffroy
Toxicologic Pathology Forum: Opinion on Not Euthanizing Control Animals in the Recovery Phase of Non-Rodent Toxicology Studies. Toxicologic pathology (2022)
Thierry D Flandre, Keith G Mansfield, Pascal J Espié, Tina Rubic-Schneider, Peter Ulrich
Immunosuppression Profile of CFZ533 (Iscalimab), a Non-Depleting Anti-CD40 Antibody, and the Presence of Opportunistic Infections in a Rhesus Monkey Toxicology Study. Toxicologic pathology 50 (5) (2022)
Chandra Saravanan, Thierry D Flandre, Carolyn L Hodo, Anne D Lewis, Lars Mecklenburg, Annette Romeike, Oliver C Turner, Hsi-Yu Yen
Research Relevant Conditions and Pathology in Nonhuman Primates. ILAR journal (2021)
Holger Hoefling, Tobias Sing, Imtiaz Hossain, Julie Boisclair, Arno Doelemeyer, Thierry D Flandre, Alessandro Piaia, Vincent Romanet, Gianluca Santarossa, Chandrassegar Saravanan, Esther Sutter, Oliver C Turner, Kuno Wuersch, Pierre Moulin
HistoNet: A Deep Learning-Based Model of Normal Histology. Toxicologic pathology 49 (4) (2021)
Anthony Peter Hall, Jeffrey S Tepper, Molly H Boyle, Maurice G Cary, Thierry D Flandre, Alessandro Piaia, Inge Tarnow, Nicholas P Macri, Mark C Freke, Kristen J Nikula, Graham R Paul, Annick Cauvin, Michela Gregori, Richard Haworth, Stuart W Naylor, Mark Price, Ian N Robinson, Andrew Allen, Tom Gelzleichter, Andreas M Hohlbaum, Scott Manetz, Alison Wolfreys, Karyn Colman, Renaud Fleurance, David Jones, Sydney Mukaratirwa
BSTP Review of 12 Case Studies Discussing the Challenges, Pathology, Immunogenicity, and Mechanisms of Inhaled Biologics. Toxicologic pathology 49 (2) (2021)
Thierry D Flandre, Alessandro Piaia, Maurice G Cary
Biologic Immunomodulatory Drugs and Infection in the Respiratory Tract of Nonhuman Primates. Toxicologic pathology 49 (2) (2020)
Thierry D Flandre, Adam S Hey, Fiona J Spence
Nonclinical Safety Assessment of an Inhaled Formulation of Serelaxin: A Recombinant Human Protein in Rats and Cynomolgus Monkeys (Macaca fascicularis). Toxicologic pathology 49 (2) (2020)